NCT00935090
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
1,630 public trials
214 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT05253495
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- University of Flordia Gainsville, Florida, United States
- New York Medical College Vallhala, New York, United States
NCT06119685
- Conditions
- Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +23 more
- Locations
-
- Valkyrie Clinical Trials Los Angeles, California, United States
- Florida Cancer Specialists and Research Institute - Lake Mary Cancer Center Lake Mary, Florida, United States
- Emory University Hospital Atlanta, Georgia, United States
- University of Minnesota Minneapolis, Minnesota, United States
Recruiting
TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL
NCT06014073
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Biotherapeutic Department, Chinese PLA General Hospital Beijing, China
- EdiGene Inc Beijing, China
- School of Life Sciences, Peking University Beijing, China
NCT06323525
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China
- Biotherapeutic Department of Chinese PLA General Hospital Beijing, China
- School of Life Sciences, Peking University Beijing, China
NCT03117036
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +8 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
NCT02964858
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Tata Memorial Center Mumbai, Maharashtra, India
Recruiting
A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies
NCT06914037
- Conditions
- Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China
Recruiting
PTCy and ATG for MSD and MUD Transplants
NCT06299462
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +20 more
- Locations
-
- Instituto Nacional de Cancer Rio de Janeiro, Brazil
Recruiting
Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma
NCT06158386
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Bing Xu Xiamen, Fujian, China